S Shinjo|P M Harrison - JoVE Visualize

Showing results (91-100 of 142) with videos related to

Pageof 15

Sort By:

Hepatology (Baltimore, Md.)|June 1, 1992

Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failureJ A Wendon, P M Harrison, R Keays, et al.

Biology of Metals|January 1, 1989

Ferritin subunits in livers of siderotic miceB Dean, S C Andrews, A Treffry, et al.

Gut|April 16, 2002

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic originT Zolfino, M A Heneghan, S Norris, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1986

Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extractionH Corbett, C M Cahill, B Heinzow, et al.

Australian and New Zealand Journal of Medicine|June 1, 1985

The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcomeA J McLean, P M Harrison, L Ioannides-Demos, et al.

FEBS Letters|February 11, 1985

Structural homology between mouse liver and horse spleen ferritinsD W Rice, B Dean, J M Smith, et al.

Journal of Inorganic Biochemistry|January 1, 1989

Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitroM C Brady, K S Lilley, A Treffry, et al.

FEBS Letters|May 18, 1992

The haemoglobin-like protein (HMP) of Escherichia coli has ferrisiderophore reductase activity and its C-terminal domain shares homology with ferredoxin NADP+ reductasesS C Andrews, D Shipley, J N Keen, et al.

European Journal of Biochemistry|April 1, 1993

Overproduction, purification and characterization of the bacterioferritin of Escherichia coli and a C-terminally extended variantS C Andrews, J M Smith, C Hawkins, et al.

British Journal of Clinical Pharmacology|January 1, 1984

Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactionsA J Byrne, J J McNeil, P M Harrison, et al.

Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:

Pageof 15

Hepatology (Baltimore, Md.)|June 1, 1992

Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failureJ A Wendon, P M Harrison, R Keays, et al.

Biology of Metals|January 1, 1989

Ferritin subunits in livers of siderotic miceB Dean, S C Andrews, A Treffry, et al.

Gut|April 16, 2002

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic originT Zolfino, M A Heneghan, S Norris, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1986

Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extractionH Corbett, C M Cahill, B Heinzow, et al.

Australian and New Zealand Journal of Medicine|June 1, 1985

The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcomeA J McLean, P M Harrison, L Ioannides-Demos, et al.

FEBS Letters|February 11, 1985

Structural homology between mouse liver and horse spleen ferritinsD W Rice, B Dean, J M Smith, et al.

Journal of Inorganic Biochemistry|January 1, 1989

Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitroM C Brady, K S Lilley, A Treffry, et al.

FEBS Letters|May 18, 1992

The haemoglobin-like protein (HMP) of Escherichia coli has ferrisiderophore reductase activity and its C-terminal domain shares homology with ferredoxin NADP+ reductasesS C Andrews, D Shipley, J N Keen, et al.

European Journal of Biochemistry|April 1, 1993

Overproduction, purification and characterization of the bacterioferritin of Escherichia coli and a C-terminally extended variantS C Andrews, J M Smith, C Hawkins, et al.

British Journal of Clinical Pharmacology|January 1, 1984

Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactionsA J Byrne, J J McNeil, P M Harrison, et al.

Pageof 15